Product identification
Medicine name:
Thyroxanil 200 microgram tablets for dogs and cats
Active substance:
- Anhydrous levothyroxine sodium
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Anhydrous levothyroxine sodium200.00/microgram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH03AA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Package description:
- Cardboard box of 2 Aluminium - PVC blisters with 25 tablets per blister.
- Cardboard box of 10 Aluminium - PVC blisters with 30 tablets per blister.
- Cardboard box of 4 Aluminium - PVC blisters with 30 tablets per blister.
- Cardboard box of 4 Aluminium - PVC blisters with 25 tablets per blister.
- Cardboard box of 1 Aluminium - PVC blister with 30 tablets per blister.
- Cardboard box of 1 Aluminium - PVC blister with 25 tablets per blister.
- Cardboard box of 7 Aluminium - PVC blisters with 30 tablets per blister.
- Cardboard box of 7 Aluminium - PVC blisters with 25 tablets per blister.
- Cardboard box of 6 Aluminium - PVC blisters with 30 tablets per blister.
- Cardboard box of 6 Aluminium - PVC blisters with 25 tablets per blister.
- Cardboard box of 5 Aluminium - PVC blisters with 25 tablets per blister.
- Cardboard box of 3 Aluminium - PVC blisters with 25 tablets per blister.
- Cardboard box of 2 Aluminium - PVC blisters with 30 tablets per blister.
- Cardboard box of 10 Aluminium - PVC blisters with 25 tablets per blister.
- Cardboard box of 9 Aluminium - PVC blisters with 30 tablets per blister.
- Cardboard box of 9 Aluminium - PVC blisters with 25 tablets per blister.
- Cardboard box of 8 Aluminium - PVC blisters with 30 tablets per blister.
- Cardboard box of 8 Aluminium - PVC blisters with 25 tablets per blister.
- Cardboard box of 5 Aluminium - PVC blisters with 30 tablets per blister.
- Cardboard box of 3 Aluminium - PVC blisters with 30 tablets per blister.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Manufacturing sites for batch release:
- Lelypharma B.V.
- Lindopharm GmbH
Authorisation number:
- 0022-2642
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0195/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Bulgarian (PDF)
Published on: 29/03/2022
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
Bulgarian (PDF)
Published on: 29/03/2022